News from generex biotechnology corporation

Jun 17, 2014, 09:30 ET

Generex Announces Interview of Dr. Eric von Hofe, President of Antigen Express, Following Recent Keynote Presentation

Generex Biotechnology Corporation (www.generex.com) (OTCBB: GNBT) today announced the posting of an interview given by Dr. Eric von Hofe, Ph.D.,...

Jun 12, 2014, 09:30 ET

Generex/Antigen Express Announce Interview of MD Anderson's Dr. Elizabeth Mittendorf, Principal Investigator on Company's AE37 Phase IIb Breast Cancer Efficacy Trial

 Generex Biotechnology Corporation (www.generex.com) (OTCBB:GNBT) today announced an interview given by Dr. Elizabeth Mittendorf, M.D., Ph.D....

Jun 10, 2014, 09:30 ET

Generex / Antigen Express to Participate in 2014 BIO International Convention

Generex Biotechnology Corporation (www.generex.com) (OTCBB:GNBT) today announced that the Company's wholly-owned subsidiary, Antigen Express, Inc....

May 20, 2014, 09:30 ET

Generex Announces Presentation of Primary Efficacy Data & Immunological Response from the Phase II Study of AE37 Cancer Vaccine at ASCO

Generex Biotechnology Corporation (www.generex.com) (OTCBB:GNBT) today announced two upcoming presentations demonstrating that certain patients...

Apr 23, 2014, 09:30 ET

Generex Announces Antigen Express AE37 Breast Cancer Vaccine Abstract Presentations at ASCO 2014 Annual Meeting

 Generex Biotechnology Corporation (www.generex.com) (OTCBB:GNBT) today announced that two abstracts in respect of results of the on-going...

Mar 27, 2014, 09:30 ET

Generex Announces $2,075,000 Capital Investment

 Generex Biotechnology Corporation (www.generex.com) (OTCBB: GNBT) today announced that it entered into a securities purchase agreement with...

Mar 26, 2014, 09:30 ET

Generex/Antigen Express Announces Participation on Panel at Upcoming Cancer Immunotherapeutics Symposium

Generex Biotechnology Corporation (www.generex.com) (OTCBB:GNBT) today announced that Dr. Eric von Hofe, Ph.D., the President of its wholly-owned...

Mar 05, 2014, 09:30 ET

Generex Subsidiary Antigen Express Receives Patents for Vaccines Targeting HPV Induced Cancers and Influenza

 Generex Biotechnology Corporation (www.generex.com) (OTCBB: GNBT) today announced that its wholly-owned subsidiary, Antigen Express, Inc....

Feb 27, 2014, 09:30 ET

Generex Announces Publication of Biomarker Studies Related to the Antigen Express Novel Immunotherapeutic AE37 in Prostate Cancer Patients

 Generex Biotechnology Corporation (www.generex.com) (OTCBB:GNBT) today announced publication of studies examining potential biomarkers...

Feb 12, 2014, 09:30 ET

Generex Provides Update on Antigen Express Phase II AE37 Breast Cancer Vaccine Trial

Generex Biotechnology Corporation (www.generex.com) (GNBT) today announced that recent results from a Phase II study of a novel cancer vaccine...

Feb 04, 2014, 11:32 ET

Generex/Antigen Express "Stock News Now" Interview Available Online

Generex Biotechnology Corporation (www.generex.com) (OTCBB: GNBT) today announced that an interview of Dr. Eric von Hofe, PhD, President of the...

Jan 13, 2014, 09:30 ET

Generex Announces Completion of Enrollment of Antigen Express Phase II AE37 Breast Cancer Vaccine Trial

 Generex Biotechnology Corporation (www.generex.com) (OTCBB:GNBT) today announced completion of enrollment of the Antigen Express, Inc....

Jan 09, 2014, 09:30 ET

Generex Announces Selection of Antigen Express Technology for Keynote Presentation at 2014 TIDES Conference

Generex Biotechnology Corporation (www.generex.com) (OTCBB:GNBT) today announced that Dr. Eric von Hofe, PhD, President of the Company's...

Jan 06, 2014, 09:00 ET

Generex/Antigen Express Announce Database Lock of AE37 Breast Cancer Vaccine Trial

Generex Biotechnology Corporation (www.generex.com) (OTCBB:GNBT) today announced the database lock for the primary efficacy analysis of its ongoing...

Nov 18, 2013, 09:00 ET

Antigen Express AE37 Breast Cancer Vaccine Update

 Generex Biotechnology Corporation (www.generex.com) (OTCBB: GNBT) today announced that it has reached a pre-specified point in the ongoing...

Sep 27, 2013, 09:30 ET

Generex Provides Update on Generex Oral-lyn™ Conference Call

 Generex Biotechnology Corporation (www.generex.com) (OTCBB:GNBT) today provided an update in respect of the previously announced conference...

Aug 20, 2013, 09:00 ET

Generex Announces Publication of Follow-up Studies from Phase I Trial of Novel Immunotherapeutic in Prostate Cancer Patients

 Generex Biotechnology Corporation (www.generex.com) (OTCBB:GNBT) today announced publication of follow up studies from a Phase I clinical...

Aug 13, 2013, 09:00 ET

Generex Announces Podium Presentation on Antigen Express Cancer Vaccine Strategy

Generex Biotechnology Corporation (www.generex.com) (OTCBB: GNBT) today announced that Dr. Eric von Hofe, Ph.D., President of its wholly-owned...

Aug 12, 2013, 09:00 ET

Generex Provides Call-In Details for Conference Call with Members of the Antigen Express Scientific Advisory Board

 Generex Biotechnology Corporation (www.generex.com) (OTCBB:GNBT) today provided call-in details for the previously announced conference call...

Jul 23, 2013, 09:00 ET

Generex Confirms Conference Call with Members of the Antigen Express Scientific Advisory Board

 Generex Biotechnology Corporation (www.generex.com) (OTCBB: GNBT) today confirmed that it will be hosting a conference call with members of...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

ReportBuyer
Research and Markets
Analysts Review